Skip to main content
. 2012 Sep 27;8(9):e1002889. doi: 10.1371/journal.ppat.1002889

Figure 4. Latent phase anti-hCMV and EBV responses in healthy persons.

Figure 4

Antiviral responses were measured in 5 healthy individuals using a panel of 14 tetramers. (A) Diversity of responses per tetramer; number of responding clones and number of V/J-genes used. (B) Rank of most abundant clone of each tetramer in the CD8 population. Median rank is 16th (range 1st–106th). (C) Visualization of anti-hCMV and anti-EBV response in one HD using 9 tetramers.